Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Receivables - Other (2020 - 2024)

Historic Receivables - Other for iSpecimen (ISPC) over the last 5 years, with Q3 2024 value amounting to $1.7 million.

  • iSpecimen's Receivables - Other rose 1603.62% to $1.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.7 million, marking a year-over-year increase of 1603.62%. This contributed to the annual value of $2.2 million for FY2023, which is 495.11% down from last year.
  • Per iSpecimen's latest filing, its Receivables - Other stood at $1.7 million for Q3 2024, which was up 1603.62% from $2.0 million recorded in Q2 2024.
  • Over the past 5 years, iSpecimen's Receivables - Other peaked at $2.3 million during Q4 2022, and registered a low of $652761.0 during Q4 2020.
  • Moreover, its 5-year median value for Receivables - Other was $1.6 million (2023), whereas its average is $1.6 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first soared by 16640.99% in 2021, then tumbled by 2510.49% in 2022.
  • Over the past 5 years, iSpecimen's Receivables - Other (Quarter) stood at $652761.0 in 2020, then surged by 166.41% to $1.7 million in 2021, then soared by 33.86% to $2.3 million in 2022, then dropped by 4.95% to $2.2 million in 2023, then decreased by 25.24% to $1.7 million in 2024.
  • Its Receivables - Other stands at $1.7 million for Q3 2024, versus $2.0 million for Q2 2024 and $2.0 million for Q1 2024.